{"Symbol": "ACET", "AssetType": "Common Stock", "Name": "Adicet Bio Inc", "Description": "Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company is headquartered in Boston, Massachusetts.", "CIK": "1720580", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "131 DARTMOUTH STREET, BOSTON, MA, UNITED STATES, 02116", "OfficialSite": "https://www.adicetbio.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "66336000", "EBITDA": "-114440000", "PERatio": "None", "PEGRatio": "0.82", "BookValue": "19.04", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-20", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-0.391", "ReturnOnEquityTTM": "-0.717", "RevenueTTM": "0", "GrossProfitTTM": "24990000", "DilutedEPSTTM": "-20", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-1", "AnalystTargetPrice": "61.5", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "7", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "9.72", "PriceToBookRatio": "0.608", "EVToRevenue": "2.139", "EVToEBITDA": "-1.211", "Beta": "1.558", "52WeekHigh": "17.44", "52WeekLow": "6.41", "50DayMovingAverage": "7.99", "200DayMovingAverage": "10.81", "SharesOutstanding": "9600000", "SharesFloat": "8405500", "PercentInsiders": "0.901", "PercentInstitutions": "61.886", "DividendDate": "2020-09-16", "ExDividendDate": "None"}